Tom Marino Expected to Be Next Drug Czar
A Pennsylvania congressman is expected to be the president’s pick to be the next drug czar. While there hasn’t been an official announcement, the head of the Pennsylvania Republican Party said Representative Tom Marino has been nominated to head national drug control policy, reported the AP. Marino, an early supporter of the president, has previously worked on legislation to expand access to treatment for people who suffer from opioid addiction.
First Drug Approved for Movement Disorder
The FDA has approved the first drug to treat tardive dyskinesia, a movement disorder caused by prescription drugs for psychiatric and gastrointestinal disorders. The Washington Post reported that no list price has been announced for Ingrezza, which is offered in a once-a-day capsule. The drug from Neurocrine Biosciences is expected to hit the market in May and could quickly face competition—a second drug for tardive dyskinesia, from Teva Pharmaceuticals, is expected to be approved in August.
Trump Still Working on Healthcare
The Trump administration isn’t quite ready to move past healthcare reform. According to Politico, President Donald Trump still wants to pass a healthcare bill before turning his attention to tax reform. However, the president is no longer putting a deadline on when a healthcare bill should pass. Although House Republicans did not have the votes to pass its plan to repeal and replace the Affordable Care Act, negotiations are still ongoing, and the House Freedom Caucus may be close to making a deal with House Speaker Paul Ryan, R-Wisconsin.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More